GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Amgen Inc (HKSE:04332) » Definitions » Shiller PE Ratio

Amgen (HKSE:04332) Shiller PE Ratio : 22.74 (As of May. 26, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Amgen Shiller PE Ratio?

As of today (2024-05-26), Amgen's current share price is HK$1761.00. Amgen's E10 for the quarter that ended in Mar. 2024 was HK$77.43. Amgen's Shiller PE Ratio for today is 22.74.

The historical rank and industry rank for Amgen's Shiller PE Ratio or its related term are showing as below:

HKSE:04332' s Shiller PE Ratio Range Over the Past 10 Years
Min: 18.58   Med: 26.81   Max: 36.6
Current: 25.71

During the past years, Amgen's highest Shiller PE Ratio was 36.60. The lowest was 18.58. And the median was 26.81.

HKSE:04332's Shiller PE Ratio is ranked worse than
52.71% of 535 companies
in the Drug Manufacturers industry
Industry Median: 24.25 vs HKSE:04332: 25.71

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Amgen's adjusted earnings per share data for the three months ended in Mar. 2024 was HK$-1.643. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is HK$77.43 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Amgen Shiller PE Ratio Historical Data

The historical data trend for Amgen's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amgen Shiller PE Ratio Chart

Amgen Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 30.03 26.12 22.55 23.60 24.23

Amgen Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.84 18.86 22.47 24.23 23.90

Competitive Comparison of Amgen's Shiller PE Ratio

For the Drug Manufacturers - General subindustry, Amgen's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Amgen's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Amgen's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Amgen's Shiller PE Ratio falls into.



Amgen Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Amgen's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=1761.00/77.43
=22.74

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Amgen's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Amgen's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-1.643/131.7762*131.7762
=-1.643

Current CPI (Mar. 2024) = 131.7762.

Amgen Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 15.581 100.560 20.418
201409 12.482 100.428 16.378
201412 13.027 99.070 17.328
201503 16.370 99.621 21.654
201506 16.669 100.684 21.817
201509 18.910 100.392 24.822
201512 18.369 99.792 24.256
201603 19.401 100.470 25.446
201606 19.172 101.688 24.845
201609 20.787 101.861 26.892
201612 20.095 101.863 25.996
201703 21.667 102.862 27.757
201706 22.693 103.349 28.935
201709 21.563 104.136 27.286
201712 -46.017 104.011 -58.301
201803 25.484 105.290 31.895
201806 27.308 106.317 33.847
201809 22.412 106.507 27.729
201812 23.536 105.998 29.260
201903 24.960 107.251 30.668
201906 27.939 108.070 34.068
201909 25.620 108.329 31.165
201912 22.243 108.420 27.035
202003 23.839 108.902 28.846
202006 23.638 108.767 28.638
202009 26.582 109.815 31.898
202012 21.395 109.897 25.655
202103 21.975 111.754 25.912
202106 6.287 114.631 7.227
202109 25.754 115.734 29.324
202112 26.205 117.630 29.357
202203 20.965 121.301 22.775
202206 19.228 125.017 20.268
202209 31.241 125.227 32.875
202212 23.356 125.222 24.579
202303 41.441 127.348 42.882
202306 20.131 128.729 20.608
202309 25.208 129.860 25.580
202312 11.090 129.419 11.292
202403 -1.643 131.776 -1.643

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Amgen  (HKSE:04332) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Amgen Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Amgen's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Amgen (HKSE:04332) Business Description

Address
One Amgen Center Drive, Thousand Oaks, CA, USA, 91320-1799
Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). The 2023 Horizon acquisition brings several rare disease drugs, including thyroid eye disease drug Tepezza. Amgen also has a growing biosimilar portfolio.

Amgen (HKSE:04332) Headlines

No Headlines